Inventor · disambiguated record
Flaminia Pavone
Also filed as: PAVONE FLAMINIA
7 granted patents·2 pending applications·160 citations·filing 1986–2019
86Inventor score
Top patents by PatentIndex Score
9 records- 0193US8691221B2Analgesic treatment with prolonged effectPAVONE FLAMINIA·Filed 2006·Granted Apr 8, 2014·94 cites·14 claims
- 0289US7988966B2Method for the potentiation of opioid analgesics effects on painLAY LINE GENOMICS SPA·Filed 2006·Granted Aug 2, 2011·23 cites·21 claims
- 0386US8715666B2Method for the potentiation of opioid analgesics effects on painPAVONE FLAMINIA·Filed 2011·Granted May 6, 2014·14 cites·23 claims
- 0471US4831155APhysostigmine derivatives with acetylcholinesterase inhibition properties, and manufactureCONSIGLIO NAZIONALE RICERCHE·Filed 1986·Granted May 16, 1989·22 cites·1 claims
- 0566US9688749B2Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effectPAVONE FLAMINIA·Filed 2006·Granted Jun 27, 2017·1 cites·20 claims
- 0658US10780149B2Therapeutic use of the botulinum neurotoxin serotype ACONSIGLIO NAZIONALE RICERCHE·Filed 2019·Granted Sep 22, 2020·0 cites·6 claims
- 0758US5306825APhysostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production processCONSIGLIO NAZIONALE RICERCHE·Filed 1989·Granted Apr 26, 1994·6 cites·3 claims
- 0844US2018140685A1A new therapeutic use of the botulinum neurotoxin serotype aCONSIGLIO NAZIONALE RICERCHE·Filed 2016·Application pending·0 cites
- 0938US2018155415A1Molecules that are able to inhibit the binding between ngf and the trka receptor as analgesics with prolonged effectPAVONE FLAMINIA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Flaminia Pavone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →